As clinicians, we know that lowering low-density lipoprotein cholesterol (LDL-C) with statins alone or in combination with nonstatin therapies such as a proprotein convertase subtilisin/kexin type 9 ...
Please provide your email address to receive an email when new articles are posted on . ApoA-I infusions may improve outcomes after acute heart attack for patients with multivessel CAD and ...
The Framingham Heart Study identified lifestyle risk factors for heart disease, including smoking, high blood pressure, and high cholesterol. A recent study suggests testing for LDL, HScrp, and ...
My cholesterol has been on the rise for the past few years – and not just a slow creep. For most of my life, my LDL (often referred to as ‘bad’ cholesterol) was solidly under 120 mg/dl. Over the past ...
New study explains why people with obesity are at a higher risk of developing cardiovascular disease
(Boston)—Obesity is a public health problem worldwide that currently affects more than 40% of adults in the U.S. Alarmingly, more than 9% of the U.S. population had severe (Class 3) obesity in 2020, ...
Nanomedicine. 2014;9(1):105-120. Overall, HDL-based siRNA delivery possesses many attractive features, including ultra-small size, favorable surface properties (no PEGylation is required for achieving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results